Chlorogiannis David-Dimitris, Sotirchos Vlasios S, Georgiades Christos, Filippiadis Dimitrios, Arellano Ronald S, Gonen Mithat, Makris Gregory C, Garg Tushar, Sofocleous Constantinos T
Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA.
Weill-Cornell Medical College, Interventional Oncology/Radiology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Cancers (Basel). 2023 Dec 12;15(24):5806. doi: 10.3390/cancers15245806.
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths in the US. Thermal ablation (TA) can be a comparable alternative to partial hepatectomy for selected cases when eradication of all visible tumor with an ablative margin of greater than 5 mm is achieved. This systematic review and meta-analysis aimed to encapsulate the current clinical evidence concerning the optimal TA margin for local cure in patients with colorectal liver metastases (CLM).
MEDLINE, EMBASE, and the CENTRAL databases were systematically searched from inception until 1 May 2023, in accordance with the PRISMA Guidelines. Measure of effect included the risk ratio (RR) with 95% confidence interval (CI) using the random-effects model.
Overall, 21 studies were included, comprising 2005 participants and 2873 ablated CLMs. TA with margins less than 5 mm were associated with a 3.6 times higher risk for LTP (n = 21 studies, RR: 3.60; 95% CI: 2.58-5.03; -value < 0.001). When margins less than 5 mm were additionally confirmed by using 3D software, a 5.1 times higher risk for LTP (n = 4 studies, RR: 5.10; 95% CI: 1.45-17.90; -value < 0.001) was recorded. Moreover, a thermal ablation margin of less than 10 mm but over 5 mm remained significantly associated with 3.64 times higher risk for LTP vs. minimal margin larger than 10 mm (n = 7 studies, RR: 3.64; 95% CI: 1.31-10.10; -value < 0.001).
This meta-analysis solidifies that a minimal ablation margin over 5 mm is the minimum critical endpoint required, whereas a minimal margin of at least 10 mm yields optimal local tumor control after TA of CLMs.
结直肠癌(CRC)是美国癌症相关死亡的第二大常见原因。对于某些病例,当能够实现切除所有可见肿瘤且消融边缘大于5mm时,热消融(TA)可成为部分肝切除术的一种可替代方法。本系统评价和荟萃分析旨在总结目前关于结直肠癌肝转移(CLM)患者实现局部治愈的最佳TA边缘的临床证据。
按照PRISMA指南,从数据库建立至2023年5月1日,对MEDLINE、EMBASE和CENTRAL数据库进行系统检索。效应量采用随机效应模型计算风险比(RR)及95%置信区间(CI)。
共纳入21项研究,包括2005名参与者和2873个经消融的CLM。TA边缘小于5mm与局部肿瘤进展(LTP)风险高3.6倍相关(n = 21项研究,RR:3.60;95% CI:2.58 - 5.03;P值<0.001)。当使用3D软件进一步确认边缘小于5mm时,记录到LTP风险高5.1倍(n = 4项研究,RR:5.10;95% CI:1.45 - 17.90;P值<0.001)。此外,热消融边缘小于10mm但大于5mm与LTP风险高3.64倍显著相关,而最小边缘大于10mm时(n = 7项研究,RR:3.64;95% CI:1.31 - 10.10;P值<0.001)。
该荟萃分析证实,消融边缘大于5mm是所需的最低关键终点,而至少10mm的最小边缘在CLM的TA后可实现最佳局部肿瘤控制。